DeutschNewstral
Article
Mmarketwatch.com on 2018-10-31 17:55
Gilead shares drop after new UnitedHealth program incentivizes cheaper HIV meds
Related news
- CCharlie Sheen goes off HIV medscontracostatimes.com
UnitedHealthThe Findlay Courier
Gilead, Merck collaborate to develop long-acting HIV treatmentThe Jerusalem Post (JPost.com)- BGilead Says Sales of Antiviral Beat Expectations as Pandemic Worsenedbarrons.com
- BGilead Sciences Stock Is Moving Back Into Favorbarrons.com
Judge rules HIV drugmaker Gilead Sciences had no obligation to release less toxic medicine earlierLA Times
Cheaper meds needednews.ubc.ca- MGilead says four late-stage trials of HIV drug combination met primary endpointsmarketwatch.com
Tax cut helps UnitedHealth earningsfinance-commerce.com
UnitedHealth puts restrictions on hysterectomiesbizjournals.com
UnitedHealth raises 2016 forecast, againdothaneagle.com
UnitedHealth quarterly profit tops forecastsThe Salt Lake Tribune
Md. groups to benefit from Gilead Sciences’ $12.6M grant to improve HIV landscape for Black women, girls thedailyrecord.com
UnitedHealth to exit California's Obamacare marketeastbaytimes.com
With elective procedures delayed, UnitedHealth profit spikesSeattle Times- UnitedHealth raises outlook after strong second quarterSeattle Times
UnitedHealth reports strong 4Q, rising costsnwaonline.com- BGilead Lays Out Plan to Produce Remdesivirbarrons.com